FILE - Newly-released inmate George Ballentine holds his prescription medicine Suboxone outside a pharmacy on July 23, 2018, in Greenfield, Mass. The attorneys general for 41 states and the District of Columbia announced a $102.5 million settlement Friday, June 2, 2023, with Suboxone maker Indivior Inc., over claims that the company schemed to keep generic competitors off the market. Suboxone, a branded version of buprenorphine and naloxone, is used to treat opioid addiction.
States, led by Wisconsin, claimed that the company, previously a subsidiary of Reckitt Benckiser Pharmaceuticals, made modest changes to Suboxone to extend patent protection and keep generic versions of the drug off the market.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more: